Lilj Uziel

710 total citations
12 papers, 356 citations indexed

About

Lilj Uziel is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Lilj Uziel has authored 12 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Lilj Uziel's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (2 papers). Lilj Uziel is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (2 papers). Lilj Uziel collaborates with scholars based in Italy, Ukraine and Australia. Lilj Uziel's co-authors include Andrés J.M. Ferreri, Michele Spina, Mario Lazzarino, Cristiana Pascutto, Massimiliano Berretta, Graziella Pinotti, Ercole Brusamolino, Umberto Tirelli, Renato Talamini and Luigi Rigacci and has published in prestigious journals such as Blood, British Journal of Haematology and Allergy.

In The Last Decade

Lilj Uziel

11 papers receiving 348 citations

Peers

Lilj Uziel
Comparison fields: 5 of 35
  • Pathology and Forensic Medicine 247
  • Genetics 144
  • Oncology 133
  • Neurology 130
  • Geriatrics and Gerontology 40
Replace Annalisa Arcari with:
Annalisa Arcari Italy
Bosko Andjelic Serbia
P. Brice France
Francesca Palombi Italy
Enzo Pavone Italy
Kevin Tay Singapore
Mohamed Touati Morocco
L. Casanova Peru
K.G. van der Hem Netherlands
Mathias Haenel Germany
Annalisa Arcari Italy View profile →
Citations per field, relative to Lilj Uziel
Lilj Uziel · 1×
Citations per year, relative to Lilj Uziel
Lilj Uziel · 1×

Countries citing papers authored by Lilj Uziel

Since Specialization
Citations

This map shows the geographic impact of Lilj Uziel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilj Uziel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilj Uziel more than expected).

Fields of papers citing papers by Lilj Uziel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilj Uziel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilj Uziel. The network helps show where Lilj Uziel may publish in the future.

Co-authorship network of co-authors of Lilj Uziel

This figure shows the co-authorship network connecting the top 25 collaborators of Lilj Uziel. A scholar is included among the top collaborators of Lilj Uziel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilj Uziel. Lilj Uziel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
# Work Indexed citations
1 91
2 19
3 2
4 2
5 69
6 9
7
Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity.
83
8 51
9 1
10 2
11 0
12 27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026